We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Cephalon Inc. (CEPH) shares jumped 10% Friday after the drug company said the government wanted more information before approving
Cephalon's proposed new treatment for cancer pain.
Avanir Pharmaceuticals today announced it has been awarded a $2 million grant from the National Institutes of Health/National Institute of Allergy and Infectious Disease (NIH/NIAID) under its Cooperative Research Partnerships for Biodefense program.
Pharmaxis today announced that a U.S. pharmaceutical company has placed an order to purchase Aridol test kits for a series of asthma trials evaluating its new asthma therapeutic.
Friday,
Bradley Pharmaceuticals Inc., a specialty pharmaceutical company, announced that it was advised by Polyphenon E ointment licensor MediGene AG that the Food and Drug Administration extended its deadline to complete a review of the product as a treatment for external genital warts.
Merck KGaA will suspenddevelopment of a new treatment for Parkinson's disease after clinical trials failedto confirm the results of earlier studies, the company said.
The European Commission (EC) has granted marketing authorization for sanofi-aventis' Acomplia in all 25 European member states, making it the first of a new type of drugs to be approved to treat obesity, the company said.
The FDA, under attack from Congress for its handling of the antibiotic Ketek, is now mandating new warnings for the drug, but may not have silenced its critics.
In observance of the Independence Day holiday, FDAnews Drug Daily Bulletin will not be published Tuesday, July 4. The next issue will be published Wednesday, July 5.